Dietary antioxidants and long-term risk of dementia

Archives of Neurology

Volumn 67, Issue 7, 2010, Pages 819-825

  Devore, Elizabeth E ^a,b,c   Grodstein, Francine ^b,c   Van Rooij, Frank J A ^a   Hofman, Albert ^a   Stampfer, Meir J ^b,c   Witteman, Jacqueline C M ^a   Breteler, Monique M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; APOLIPOPROTEIN E4; ASCORBIC ACID; BETA CAROTENE; FLAVONOID;

ADULT; AGED; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ARTICLE; BODY MASS; CALORIC INTAKE; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; FOLLOW UP; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NETHERLANDS; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK REDUCTION; SMOKING;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; APOLIPOPROTEINS E; BETA CAROTENE; COHORT STUDIES; COMMUNITY HEALTH PLANNING; DEMENTIA; DIETARY SUPPLEMENTS; FEMALE; FLAVONOIDS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; VITAMINS;

EID: 77955043040     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.144     Document Type: Article

References (32)

1. Behl C. Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res. 1997;290(3):471-480.
2. Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr. 2000;71(2):621S-629S.
3. Montiel T, Quiroz-Baez R, Massieu L, Arias C. Role of oxidative stress on β-amyloid neurotoxicity elicited during impairment of energy metabolism in the hippocampus: protection by antioxidants. Exp Neurol. 2006;200(2):496-508.
4. Rota C, Rimbach G, Minihane AM, Stoecklin E, Barella L. Dietary vitamin Emodulates differential gene expression in the rat hippocampus: potential implications for its neuroprotective properties. Nutr Neurosci. 2005;8(1):21-29. (Pubitemid 40637244)
5. Yamada K, Tanaka T, Han D, Senzaki K, Kameyama T, Nabeshima T. Protective effects of idebenone and α-tocopherol on β-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in β-amyloid-induced neurotoxicity in vivo. Eur J Neurosci. 1999;11(1):83-90.
6. Socci DJ, Crandall BM, Arendash GW. Chronic antioxidant treatment improves the cognitive performance of aged rats. Brain Res. 1995;693(1-2):88-94.
7. Joseph JA, Shukitt-Hale B, Denisova NA, et al. Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J Neurosci. 1998;18(19):8047-8055.
8. Joseph JA, Shukitt-Hale B, Denisova NA, et al. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci. 1999;19(18):8114-8121. (Pubitemid 30225807)
9. Petersen RC, Thomas RG, Grundman M, et al; Alzheimer's Disease Cooperative Study Group. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352(23):2379-2388.
10. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, α-tocopherol, or both as treatment for Alzheimer's disease: the Alzheimer's Disease Cooperative Study. N Engl J Med. 1997;336(17):1216-1222.
11. Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA. 2002;287(24):3230-3237.
12. Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger-Gateau P, Dartigues JF. Intake of flavonoids and risk of dementia. Eur J Epidemiol. 2000;16(4):357-363.
13. Luchsinger JA, Tang MX, Shea S, Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol. 2003;60(2):203-208.
14. Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2002;287(24):3223-3229.
15. Hofman A, Breteler MM, van Duijn CM, et al. The Rotterdam Study: objectives and design update. Eur J Epidemiol. 2007;22(11):819-829.
16. Launer LJ. The epidemiologic study of dementia: a life-long quest? Neurobiol Aging. 2005;26(3):335-340.
17. Berr C, Balansard B, Arnaud J, Roussel AM, Alperovitch A. Cognitive decline is associated with systemic oxidative stress: the EVA study: Etude du Vieillissement Arteriel. J Am Geriatr Soc. 2000;48(10):1285-1291.
18. Nunomura A, Perry G, Aliev G, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol. 2001;60(8):759-767.
19. Praticò D, Clark CM, Liun F, Rokach J, Lee VY, Trojanowski JQ. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol. 2002;59(6):972-976. (Pubitemid 34640757)
20. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX: a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986;149:698-709.
21. Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A. Incidence and risk of dementia: the Rotterdam Study. Am J Epidemiol. 1998;147(6):574-580. (Pubitemid 28134244)
22. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
23. Copeland JR, Kelleher MJ, Kellett JM, et al. A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule, I: development and reliability. Psychol Med. 1976;6(3):439-449.
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, revised. Washington, DC: American Psychiatric Association; 1987.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939-944.
26. Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250-260.
27. Klipstein-Grobusch K, den Breeijen JH, Goldbohm RA, et al. Dietary assessment in the elderly: validation of a semiquantitative food frequency questionnaire. Eur J Clin Nutr. 1998;52(8):588-596. (Pubitemid 28395698)
28. Fan C. Dutch Food and Nutrition Table (NEVO). The Hague, the Netherlands: Voorlichtingsbureau voor de Voeding; 2006.
29. Slooter AJ, Cruts M, Kalmijn S, et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol. 1998;55(7):964-968.
30. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986;124(1):17-27. (Pubitemid 16095831)
31. Laurin D, Masaki KH, Foley DJ, White LR, Launer LJ. Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study. Am J Epidemiol. 2004;159(10):959-967.
32. Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Diet and risk of dementia: does fat matter? the Rotterdam Study. Neurology. 2002;59(12):1915- 1921. (Pubitemid 36076564)